Digipath
CHM Cannabis
Home > Boards > US Listed > Medical - Equipment >

InspireMD, Inc. (NSPR)

NSPR RSS Feed
Add NSPR Price Alert      Hide Sticky   Hide Intro
Moderator: Value_Investor, 420man
Search This Board: 
Last Post: 12/12/2018 10:35:58 AM - Followers: 82 - Board type: Free - Posts Today: 0

Great Europe-Patent News for NSPR (01.05.2017):
 https://register.epo.org/application?number=EP07827415

NSPR is still one of the Cheapest NYSE stocks based on the New BV & CV! The 10-Q confirms its 100% Debt-Free financial status which is the most important fundamental for a big board stock ! 

https://register.epo.org/application?number=EP07827415 
https://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-113000992.html 
http://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-110000931.html 
http://finance.yahoo.com/news/inspiremd-cguard-tm-embolic-prevention-133200180.html 
http://www.marketwatch.com/story/inspiremd-repays-term-note-ahead-of-schedule-2017-03-22?siteid=bigcharts&dist=bigcharts 


InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.

Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
 

Our Technology

MicroNetTM

The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.

MicroNetTM key features:

  • PET is a bio-stable synthetic fiber widely used in a variety of industries.
    Attached and secured to the proximal and the distal crowns of the stent.
    Does not alter the procedure as it expands with the stent.
    Pore size is typically between 150 – 180 µm. 
     

CGuard™

need for tapered version


Carotid Embolic Prevention System

The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.

Product Details:

  • CGuard material: Nitinol
MicroNet material: Polyethylene Terephthalate (PET)
  • Easy to use RX (Rapid Exchange) delivery system
     

MGuard™

Improving Clinical Outcomes For STEMI Patients

The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.

While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard material: Stainless Steel 316 
  • MicroNet material: Polyethylene Terephthalate (PET)

     

MGuard Prime™

Improving Clinical Outcomes For STEMI Patients

The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.

While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard Prime material: Cobalt Chromium (CoCr) L605

MicroNet material: Polyethylene Terephthalate (PET)
  • Superior flexibility and excellent deliverability

http://www.inspiremd.com/en/products/the-technology/
 

2017 News

Thursday23March 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…

Wednesday22March 2017

InspireMD Repays Term Note Ahead of Schedule

Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…

Tuesday21March 2017

InspireMD Announces Distribution Agreement for CGuard™ EPS in Hong Kong

BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Monday20March 2017

InspireMD Announces CGuardTM Distribution Agreement for the Russian Federation

Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Wednesday15March 2017

InspireMD Reports Continued Progress in the Transition of European Sales and Distribution

Announces Agreements with Leading Distributors in the Baltic States   BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…

Tuesday14March 2017

InspireMD Announces Closing of Public Offering of Approximately $6.8 Million

BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday09March 2017

InspireMD Announces Pricing of Public Offering of up to $7.5 Million

BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday16February 2017

InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets   BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…

Tuesday24January 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at LINC 2017

PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…

Contact Us

Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at info@inspiremd.com or 1-888-776-6804.

Executives

James J. BarryPresident & Chief Executive Officer

Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…

Craig ShoreChief Financial Officer

Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…

Agustin GagoExecutive Vice President and Chief Commercial Officer

Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…

Benzi SpectorHead of R&D and Operations

Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….

Sharon ShacharHead of Regulatory and Quality

Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies.   Prior to joining InspireMD, she…

Website:  http://www.inspiremd.com/en/

 

Digipath
CHM Cannabis
NSPR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#2016  Sticky Note NSPR has Very Good News today --- see Value_Investor 11/28/18 08:33:30 AM
#2031   It seems $0.1701 will be confirmed a New Value_Investor 12/12/18 10:35:57 AM
#2030   Not sure what's going on here, but they 420man 12/10/18 05:54:05 PM
#2029   Wow, NSPR declined to $0.175 so far! Its Value_Investor 12/10/18 11:32:07 AM
#2028   NSPR is finally Up 11.1% from its New Value_Investor 12/07/18 10:32:53 AM
#2027   11/20's New low $0.191 will be tested again Value_Investor 12/05/18 05:15:56 PM
#2026   NSPR declined further to a New Lower daily Value_Investor 12/04/18 04:26:09 PM
#2025   Watching in disbelief! I'm returning to my initial 420man 12/03/18 11:28:06 AM
#2024   NSPR just crashed to a New Lower daily Value_Investor 12/03/18 11:26:21 AM
#2023   It's actually really sad that even good news 420man 12/01/18 02:57:42 PM
#2022   And so on and so forth jarubr 12/01/18 11:28:11 AM
#2021   As I predicted yesterday NSPR just crashed to Value_Investor 11/30/18 01:33:32 PM
#2020   I'm so glad to have sold all my Value_Investor 11/29/18 12:14:22 PM
#2019   SAD... Someone's gotta a lot of shares to 420man 11/28/18 10:07:39 AM
#2018   Only a matter of time before people realize 420man 11/28/18 08:43:27 AM
#2017   Agreed 420man 11/28/18 08:36:56 AM
#2016   NSPR has Very Good News today --- see Value_Investor 11/28/18 08:33:30 AM
#2015   That's the news I've been waiting and hoping 420man 11/28/18 08:32:35 AM
#2014   NSPR won't break out the narrow price box Value_Investor 11/27/18 10:41:16 PM
#2011   No. NSPR has Bad News today --- insider's Value_Investor 11/26/18 05:26:31 PM
#2010   True...NSPR will not make a significant move north 420man 11/23/18 10:28:22 AM
#2009   Furthermore, when you enter these markets, you're entering RamiroGaliza 11/23/18 03:06:47 AM
#2008   Tomsen; I'm not saying that NSPR management are RamiroGaliza 11/23/18 02:58:04 AM
#2007   Just wanted to correct what i posted toward tomsen 11/22/18 06:43:31 PM
#2006   NSPR Best in class period!!! Keep it simple !!! levelhead 11/22/18 05:11:55 PM
#2005   NSPR GOING UP!!!! levelhead 11/22/18 05:06:29 PM
#2004   I understand you. What you're saying, word per RamiroGaliza 11/22/18 03:04:39 PM
#2003   What I am saying is that only a tomsen 11/22/18 01:29:21 PM
#2002   NSPR will be traded in the narrow price Value_Investor 11/22/18 01:07:46 PM
#2001   You are saying that buyout isn't going to RamiroGaliza 11/22/18 02:26:28 AM
#2000   Regarding current product and pipeline, NSPR does have RamiroGaliza 11/22/18 02:20:30 AM
#1999   I'm not saying that reality was good; I'm RamiroGaliza 11/22/18 01:59:23 AM
#1998   That's the question. Very good news are imminent. RamiroGaliza 11/22/18 01:41:46 AM
#1997   Only 8.51% of this company is owned by tomsen 11/21/18 01:54:03 PM
#1996   You defend management, but all you have to tomsen 11/21/18 01:19:50 PM
#1995   Without very good news I don't think NSPR Value_Investor 11/21/18 10:54:00 AM
#1994   I think that people should stop complaining about RamiroGaliza 11/21/18 03:03:44 AM
#1993   If you all have followed or have read tomsen 11/20/18 01:05:54 PM
#1992   NSPR declined to $0.191 so far while last Value_Investor 11/20/18 11:36:39 AM
#1991   I think that delay in releasing news / RamiroGaliza 11/20/18 08:43:31 AM
#1990   AM!!! 420man 11/19/18 10:22:18 PM
#1989   Agreed!!! I doubt news will come this week 420man 11/19/18 06:57:49 PM
#1988   NSPR needs some very good news in order Value_Investor 11/19/18 12:52:40 PM
#1987   This week. Press release hasn't to be just RamiroGaliza 11/19/18 03:21:05 AM
#1986   Thanks for that information. Waiting for press release RamiroGaliza 11/18/18 02:12:33 PM
#1985   Saturday From the IRONGUARD 2 Multicenter Italian Registry STUDY jarubr 11/17/18 08:38:26 PM
#1984   On Friday jarubr 11/17/18 08:05:04 PM
#1983   Today is another decline day after yesterday's mini-bounce Value_Investor 11/16/18 04:29:04 PM
#1982   I think that the important date will be jarubr 11/16/18 07:14:01 AM
#1981   NSPR declined to the lower daily low $0.1956 Value_Investor 11/15/18 10:37:00 AM
#1980   There are too two presentations on friday for RamiroGaliza 11/14/18 02:53:05 PM
PostSubject